Crestline Management’s Lam Research LRCX Stock Holding History

Crestline Management’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-56,000	Closed	-$4.03M	–	302
2021 Q4	$4.03M	Buy	+56,000	New	+$3.51M	0.3%	66
2021 Q2	–	Sell	-75,000	Closed	-$4.46M	–	207
2021 Q1	$4.46M	Buy	+75,000	New	+$4.09M	0.57%	16
2020 Q4	–	Sell	-60,000	Closed	-$1.99M	–	159
2020 Q3	$1.99M	Sell	60,000 -55,000	-48%	-$1.89M	0.29%	52
2020 Q2	$3.72M	Sell	115,000 -32,820	-22%	-$895K	0.68%	20
2020 Q1	$3.55M	Buy	+147,820	New	+$4.26M	1.02%	9
2018 Q4	–	Sell	-455,480	Closed	-$6.91M	–	126
2018 Q3	$6.91M	Buy	455,480 +325,480	+250%	+$5.56M	0.64%	10
2018 Q2	$2.25M	Buy	+130,000	New	+$2.5M	0.24%	122
2017 Q1	–	Sell	-53,870	Closed	-$570K	–	129
2016 Q4	$570K	Sell	53,870 -37,210	-41%	-$378K	0.14%	49
2016 Q3	$863K	Buy	+91,080	New	+$829K	0.11%	97

Other funds holding LRCX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Crestline Management's LRCX Position: Q1 2022 in Review

Crestline Management sold out of Lam Research (LRCX) in Q1 2022, closing a stake of 56,000 shares — an estimated $4.03M sold.

Crestline Management first reported a position in LRCX in Q3 2016 and held it in 9 quarters. The position peaked at $6.91M in Q3 2018. 1,389 funds tracked by Wall St. Rank hold LRCX as of Q1 2022.

Crestline Management reported no remaining Lam Research position as of Q1 2022 after selling out during the quarter.
Crestline Management sold 56,000 Lam Research shares in Q1 2022, an estimated $4.03M.
Crestline Management first reported a position in Lam Research in Q3 2016 and held it in 9 quarters.
Crestline Management's Lam Research position peaked at $6.91M in Q3 2018.
1,389 funds tracked by Wall St. Rank held Lam Research as of Q1 2022.

Based on Crestline Management's 13F filing for Q1 2022, filed 16 May 2022.